Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

PF429242 dihydrochloride

Copy Product Info
🥰Excellent
Catalog No. T12437Cas No. 2248666-66-0

PF429242 dihydrochloride is a reversible and competitive inhibitor of S1P, with an IC50 of 175 nM.

PF429242 dihydrochloride

PF429242 dihydrochloride

Copy Product Info
🥰Excellent
Purity: 99.68%
Catalog No. T12437Cas No. 2248666-66-0
PF429242 dihydrochloride is a reversible and competitive inhibitor of S1P, with an IC50 of 175 nM.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$36In StockIn Stock
5 mg$85In StockIn Stock
10 mg$123In StockIn Stock
25 mg$247In StockIn Stock
50 mg$372In StockIn Stock
100 mg$558In StockIn Stock
1 mL x 10 mM (in DMSO)$94In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.68%
Appearance:Viscous
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
PF429242 dihydrochloride is a reversible and competitive inhibitor of S1P, with an IC50 of 175 nM.
Targets&IC50
S1P:175 nM
In vitro
10 μM PF-429242 down-regulates the signal from an SRE-luciferase reporter gene in human embryonic kidney 293 cells and the expression of endogenous SREBP target genes in cultured HepG2 cells. In HepG2 cells, PF-429242 inhibits cholesterol synthesis, with an IC50 of 0.5 μM[1]. PF-429242 treatment also shows suppressive effects on DENV2 yields in the cultured fluids of human-derived HEK-293, Hep G2, and non-human-primate derived LLC-MK2 cells[2]. PF-429242 has potent antiviral against LCMV and LASV [3].
In vivo
PF-429242 inhibits the expression of hepatic SREBP target genes, and the hepatic rates of cholesterol and fatty acid synthesis are reduced In mice[1].
Chemical Properties
Molecular Weight482.49
FormulaC25H37Cl2N3O2
Cas No.2248666-66-0
SmilesCl.Cl.CCN(CC)Cc1ccc(cc1)C(=O)N(CCc1ccccc1OC)[C@@H]1CCNC1
Relative Density.no data available
Storage & Solubility Information
StoragePure form: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
H2O: 50 mg/mL (103.63 mM), Sonication is recommended.
DMSO: 83.3 mg/mL (172.65 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 3.3 mg/mL (6.84 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
H2O/DMSO
1mg5mg10mg50mg
1 mM2.0726 mL10.3629 mL20.7258 mL103.6291 mL
5 mM0.4145 mL2.0726 mL4.1452 mL20.7258 mL
10 mM0.2073 mL1.0363 mL2.0726 mL10.3629 mL
20 mM0.1036 mL0.5181 mL1.0363 mL5.1815 mL
50 mM0.0415 mL0.2073 mL0.4145 mL2.0726 mL
100 mM0.0207 mL0.1036 mL0.2073 mL1.0363 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy PF429242 dihydrochloride | purchase PF429242 dihydrochloride | PF429242 dihydrochloride cost | order PF429242 dihydrochloride | PF429242 dihydrochloride chemical structure | PF429242 dihydrochloride in vivo | PF429242 dihydrochloride in vitro | PF429242 dihydrochloride formula | PF429242 dihydrochloride molecular weight